Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00866
Species: Homo sapiens
Position : chr13:42956000-42956832
Year: 2018
Title: Multiple Functional Variants at 13q14 Risk Locus for Osteoporosis Regulate RANKL Expression Through Long-Range Super-Enhancer.
Genome Build: hg19
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: osteoporosis
PMID:  29528523
MONDO: MONDO:0005298
Tissue: bone
Cell Source: U2OS
CVCL ID: CVCL_0042
Cell Type: osteosarcoma-derived osteoblast-like cell
Experiment Type: Risk-variant regulatory analysis; super-enhancer annotation; enhancer-gene interaction
High Throughput Method: GWAS/eQTL; Hi-C; ChIP-seq/RNA-seq integration; eQTL analysis
Low Throughput Method: Reporter/qRT-PCR/ChIP-qPCR validation for selected functional variants/constituents; CRISPR-Cas9; Luciferase reporter assay
About Target Gene
Target gene : TNFSF11
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 5 found
Enhancer ID Position Tissue Cell Disease
E_00871 chr13:42939000-42967000 bone marrow hematopoietic stem/progenitor cell osteoporosis
E_00872 chr13:42939000-42967000 blood B-lymphoblastoid cell osteoporosis
E_00873 chr13:42939000-42967000 bone osteosarcoma-derived osteoblast-like cell osteoporosis
E_00861 chr13:42956000-42956832 bone marrow hematopoietic stem/progenitor cell osteoporosis
E_00862 chr13:42956000-42956832 blood B-lymphoblastoid cell osteoporosis
Expression of Target Genes for the Enhancer